Beam Therapeutics Inc.
USD26.33
-1.20 (-4.36%)
CEO
John Evans
IPO Date
2020-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.73
Prev. Close
$27.53
Day Low
$26.19
Day High
$28.13
52W Low
$15.60
52W High
$38.26
Market Cap
$2.71B
Volume
2.74M
| 18,663 |
| $0.67 |
| 1 Jul 2026 | Evans John M. | director, officer: CEO | M-Exempt | Acquired | 25,000 | $1.03 |
| 1 Jul 2026 | Evans John M. | director, officer: CEO | S-Sale | Disposed | 13,421 | $35.13 |
| 1 Jul 2026 | Evans John M. | director, officer: CEO | S-Sale | Disposed | 11,579 | $35.91 |
| 1 Jul 2026 | Evans John M. | director, officer: CEO | S-Sale | Disposed | 23,100 | $34.26 |
| 1 Jul 2026 | Evans John M. | director, officer: CEO | S-Sale | Disposed | 1,900 | $34.84 |
| 1 Jul 2026 | Evans John M. | director, officer: CEO | M-Exempt | Disposed | 18,663 | $0.67 |
| 1 Jul 2026 | Evans John M. | director, officer: CEO | M-Exempt | Disposed | 6,337 | $1.03 |
| 1 Jul 2026 | Evans John M. | director, officer: CEO | M-Exempt | Disposed | 25,000 | $1.03 |